45% of patients keep weight off a year after stopping GLP-1 drugs - real-world data challenges trial fears
Real-world data from 7,938 patients show that stopping GLP-1 drugs leads to minimal average weight regain, with 45% of obesity patients continuing to lose weight or maintaining their loss at one year - largely because 47% restart medication or switch to alternatives.